Differential Treatment Responses in Pakistani Schizophrenia Samples: Correlation with Sociodemographic Parameters, Drug Addiction, Attitude to the Treatment and Antipsychotic Agents

Schizophrenia patients demonstrate variations in response to different therapies that are currently being used for the treatment of disorders, such as augmentation therapy (ECT or mood stabilizer) and combination therapy (with antipsychotics). These therapies are also used to treat schizophrenia pat...

Full description

Bibliographic Details
Published in:	Brain Sciences
Main Authors:	Umme Habiba, Aafia Malik, Ghazala Kaukab Raja, Muhammad Raza Memon, Asad Tameezud din Nizami, Rafaqat Ishaq, Muhammad Ilyas, Hadi Valadi, Muhammad Nawaz, Pakeeza Arzoo Shaiq
Format:	Article
Language:	English
Published:	MDPI AG 2023-02-01
Subjects:	schizophrenia hallucinations medication antipsychotics
Online Access:	https://www.mdpi.com/2076-3425/13/3/407

Similar Items

Clearing the Fog: A Review of Antipsychotics for Parkinson's-Related Hallucinations: A Focus on Pimavanserin, Quetiapine and Clozapine
by: Toufik Abdul-Rahman, et al.
Published: (2024-04-01)

Diagnostic challenge in neuropsychiatry: two case reports
by: Leonavičius Rytis, et al.
Published: (2012-06-01)

Treatment of antipsychotic-induced parkinsonism in schizophrenic patients
by: E. E. Vaiman, et al.
Published: (2021-08-01)

Repurposing Antipsychotics for Cancer Treatment
by: Nikolaos Vlachos, et al.
Published: (2021-11-01)

Sexual hallucinations: Under-reported yet distressing symptom of schizophrenia – A case series
by: Koushik Das, et al.
Published: (2025-01-01)

Atypical antipsychotics in the treatment of schizophrenia
by: Swiss Medical Weekly
Published: (2003-02-01)

Comparative Analysis of Time to All-cause Treatment Discontinuation and Rehospitalization among Early-phase Schizophrenia Patients Discharged on Long-acting Injectable Antipsychotics versus Oral Antipsychotics
by: Ta-Chun Lin, et al.
Published: (2025-01-01)

The treatment characteristics of oral antipsychotics in treatment of adolescents with schizophrenia in China
by: Huaning Wang, et al.
Published: (2025-07-01)

Pharmacoeconomic assessment of antipsychotic treatment in outpatients with schizophrenia
by: I. A. Vilyum, et al.
Published: (2018-05-01)

Pharmacogenetics and Schizophrenia—Can Genomics Improve the Treatment with Second-Generation Antipsychotics?
by: Olga Płaza, et al.
Published: (2022-12-01)

Comparison of antipsychotic prescribing practices following failure of antipsychotic monotherapy in the acute care setting
by: Kaitlyn Morgan, PharmD, BCPP, et al.
Published: (2023-01-01)

The Novel Antipsychotic Lumateperone (Iti-007) in the Treatment of Schizophrenia: A Systematic Review
by: Giulio Longo, et al.
Published: (2023-11-01)

Combination treatment with second generation antipsychotics other than clozapine
by: C. Schmidt-Kraepelin
Published: (2021-04-01)

Monitoring of antipsychotic plasma levels in the assessment of poor response and nonadherence to antipsychotics in delusional disorder
by: A. González-Rodríguez, et al.
Published: (2021-04-01)

Sexual disfunction in adolescents with antipsychotics. evaluation and suitability of the treatment
by: S. Pérez Sánchez, et al.
Published: (2021-04-01)

Leukopenia and agranulocytosis in atypical antipsychotic treatment - besides clozapine
by: B. Jorge, et al.
Published: (2021-04-01)

Antipsychotics and rashes
by: Jessica Lin
Published: (2018-11-01)

Can atypical antipsychotic drugs cause hepatotoxicity?
by: R. André, et al.
Published: (2021-04-01)

Screening, Diagnosis, and Management of Parkinson’s Disease Psychosis: Recommendations From an Expert Panel
by: Rajesh Pahwa, et al.
Published: (2022-07-01)

The use of antipsychotics in the treatment of catatonia: a systematic review
by: Maximilien Redon, et al.
Published: (2025-01-01)

Hyperhomocysteinemia in Treatment with Atypical Antipsychotics is Independent of Metabolic Syndrome
by: Emre Sarandöl, et al.
Published: (2023-12-01)

Priapism secondary to antipsychotic treatments with favorable response to amisulpride
by: A. Pérez Balaguer, et al.
Published: (2022-06-01)

Use of antipsychotics with tamoxifen
by: H. Ghabi, et al.
Published: (2021-04-01)

antipsychotics and metabolic syndrome
by: R. Jomli, et al.
Published: (2022-06-01)

Intellectual disability and antipsychotics
by: I. Cuevas Iñiguez, et al.
Published: (2021-04-01)

Recent trends in antipsychotic polypharmacy in the treatment of schizophrenia
by: Norio Yasui‐Furukori, et al.
Published: (2020-09-01)

Exercise and Worsening of Extrapyramidal Symptoms during Treatment with Long-Acting Injectable Antipsychotics
by: David D. Kim, et al.
Published: (2021-07-01)

Practical Guidance for the Use of Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia
by: Riboldi I, et al.
Published: (2022-12-01)

Demographic and Clinical Determinants of Tuberculosis and TB Recurrence: A Double-Edged Retrospective Study from Pakistan
by: Mariam Ahmed Mujtaba, et al.
Published: (2022-01-01)

Transitions of care: Assessment of adherence to long-acting injectable antipsychotic treatment following discharge from inpatient psychiatry
by: Charnae Ross, PharmD, MSHA, BCSCP, et al.
Published: (2025-02-01)

Efficacy and Tolerance of Antipsychotics Used for the Treatment of Patients Newly Diagnosed with Schizophrenia: A Systematic Review and Meta-Analysis
by: Zina Sherzad Qadir, et al.
Published: (2023-11-01)

Dosage and duration of antipsychotic treatment in demented outpatients with agitation or psychosis
by: Yi-Ting Lin, et al.
Published: (2015-02-01)

Clinical Utility and Implementation of Pharmacogenomics for the Personalisation of Antipsychotic Treatments
by: Marta Hernandez, et al.
Published: (2024-02-01)

Carbamazepine in treatment of visual hallucinations: A case of chronic hallucinatory psychosis
by: Sayantanava Mitra, et al.
Published: (2015-01-01)

Effectiveness of oral versus long-acting antipsychotic treatment early-phase schizophrenia patients: an open-label randomized trial
by: I. Winter, et al.
Published: (2022-06-01)

Antipsychotic-induced Hyperprolactinemia
by: Suheyla Dogan Bulut, et al.
Published: (2015-06-01)

Onset of Action of Selected Second-Generation Antipsychotics (Pines)–A Systematic Review and Meta-Analyses
by: Rikke Meyer, et al.
Published: (2022-12-01)

Prescription of Anticholinergic Drugs in Patients With Schizophrenia: Analysis of Antipsychotic Prescription Patterns and Hospital Characteristics
by: Hikaru Hori, et al.
Published: (2022-05-01)

Antipsychotics use in dementia: How safe are they?
by: C. Lopes
Published: (2021-04-01)

Antipsychotic polypharmacy in a regional health service: a population-based study
by: Bernardo Miguel, et al.
Published: (2012-05-01)